Neurexan

Medicinal product

(Invented) name

Neurexan

Active substance (s)

Avena sativa D2/Coffea arabica D12/Passiflora incarnata D2/Zincum isovalerianicum D4

Strength

0,6 mg/0,6 mg/0,6 mg/0,6 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

Marketing authorisation holder

Biologische Heilmittel Heel GmbH, Vokietija

Date of authorisation

2013-02-13

Date of renewal

2019-01-17

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

16.2

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
50692	64580	1064580	tablečių talpyklė	N50		Nereceptinis	LT/1/13/3207/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2019-01-17	Perregistruotas
2013-02-13	Registruotas